Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska IK, Pantelaiou-Prokaki G, Prokakis E, Schmidt GE, Müller-Kirschbaum LC, Werner M, Sen M, Velychko T, Jannasch K, Dullin C, Napp J, Pantel K, Wikman H, Wiese M, Kramm CM, Alves F, Wegwitz F.
Mieczkowska IK, et al. Among authors: prokakis e.
Cell Death Dis. 2021 Nov 29;12(12):1118. doi: 10.1038/s41419-021-04407-y.
Cell Death Dis. 2021.
PMID: 34845197
Free PMC article.